Oral Oncology
Volume 46, Issue 9 , Pages 644-647, September 2010

Endothelins and their receptors as biological markers for oral cancer

  • Renata R. Hoffmann

      Affiliations

    • Postgraduate Program of Dental College, PUCRS, Brazil
  • ,
  • Liliane S. Yurgel

      Affiliations

    • Postgraduate Program of Dental College, PUCRS, Brazil
    • Stomatology Service, Hospital São Lucas, PUCRS, Brazil
  • ,
  • Maria M. Campos

      Affiliations

    • Postgraduate Program of Dental College, PUCRS, Brazil
    • Institute of Toxicology, PUCRS, Brazil
    • Corresponding Author InformationCorresponding author at: School of Dentistry, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga, 6681, Partenon, 90619-900 Porto Alegre, Brazil. Tel.: +55 51 3320 3562; fax: +55 51 3320 3626.

Received 9 June 2010; received in revised form 24 June 2010; accepted 25 June 2010. published online 26 July 2010.

Summary 

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies recognized nowadays, and represents a public health problem. Its early detection is the better alternative to provide a good quality of life for the patients. During the last years, several studies have identified potential biomarkers of OSCC progression and prognosis. Endothelins and their receptors are involved in several pathophysiological conditions and in various cancer types. The present review article discusses whether the endothelin system would represent a biomarker for OSCC.

Keywords: Oral cancer, Endothelin-1, Endothelin receptors, Prognostic factor

Abbreviations: OSCC, oral squamous cells carcinoma, ET-1, endothelin-1, ET-2, endothelin-2, ET-3, endothelin-3, ETs, endothelins, ECE, endothelin-converting enzyme, ETAR, endothelin receptor A, ETBR, endothelin receptor B

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(10)00199-5

doi:10.1016/j.oraloncology.2010.06.015

Oral Oncology
Volume 46, Issue 9 , Pages 644-647, September 2010